Brainsway* has launched a new era in the treatment of major depressive disorder, with Brainsway Deep TMS (Transcranial Magnetic Stimulation). With this advanced treatment, patients can regain stability, calm and happiness in just a few weeks.
Brainsway's TMS therapy is effective*, safe and generally well-tolerated* for patients with treatment-resistant depression. It is FDA cleared* for patients who tried several types of antidepressants without improving. Our Deep TMS therapy is non-invasive, does not generate systemic side effects*, and does not require hospitalization or anesthesia.
Brainsway Deep TMS treatment stimulates the brain regions responsible for depression in a non-invasive way, using brief magnetic fields, at an amplitude similar to that used in magnetic resonance imaging (MRI) systems.
Brainsway's Deep Transcranial Magnetic Stimulation has been widely tested, participating in over 60 clinical trials worldwide. It is based on patents registered by the U.S. National Institutes of Health (NIH) and the company.